“We are thrilled to be working with LMT Surgical to provide the support and training for the growing demand for our MolecuLight i:X point-of-care device in Australia and New Zealand,” says Anil Amlani, MolecuLight’s CEO. “We believe that LMT, with its impressive team and strong relationships with the leading clinicians and medical institutions, is the perfect partner for MolecuLight.”
“We are very excited to start collaborating with MolecuLight and promote the i:X system in Australia and New Zealand. The MolecuLight i:X device will complement our extensive wound care portfolio seamlessly,” says Daniel Jones, General Manager Sales & Marketing of LMT Surgical.
LMT joins MolecuLight’s Global Distribution Network which distributes and supports its products internationally. MolecuLight maintains a direct Sales and Clinical Applications Support team in the United States and Canada.
To book a demonstration of the MolecuLight i:X technology in Australia or New Zealand, please contact info@lmtsurgical.com.
About LMT Surgical
LMT Surgical is a leading provider of products and services…
